Ken Griffin Intercure Ltd. Transaction History

Citadel Advisors LLC

$550 Billion
Q2 2025

A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Intercure Ltd. stock. As of the latest transaction made, Citadel Advisors LLC holds 41,068 shares of INCR stock, worth $71,047. This represents 0.0% of its overall portfolio holdings.

Number of Shares

41,068

Previous 1,600 2466.75%

Holding current value

$71,047

Previous $2,000 2900.0%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	SELL	$1.22 - $1.6 $1,523 - $1,998	-1,249 Reduced 2.95%	41,068 $60,000
Q1 2025 May 15, 2025	BUY	$1.4 - $1.75 $233 - $292	167 Added 0.4%	42,317 $59,000
Q4 2024 Feb 14, 2025	SELL	$1.17 - $1.87 $10,017 - $16,010	-8,562 Reduced 16.88%	42,150 $67,000
Q3 2024 Nov 14, 2024	SELL	$1.71 - $2.62 $995 - $1,524	-582 Reduced 1.13%	50,712 $101,000
Q2 2024 Aug 14, 2024	BUY	$1.97 - $3.62 $14,879 - $27,341	7,553 Added 17.27%	51,294 $103,000
Q1 2024 May 15, 2024	SELL	$1.18 - $2.71 $11,338 - $26,040	-9,609 Reduced 18.01%	43,741 $118,000
Q4 2023 Feb 14, 2024	BUY	$1.01 - $1.62 $817 - $1,310	809 Added 1.54%	53,350 $68,000
Q3 2023 Nov 14, 2023	BUY	$1.39 - $1.72 $20,093 - $24,864	14,456 Added 37.96%	52,541 $82,000
Q2 2023 Aug 14, 2023	SELL	$1.7 - $2.6 $18,363 - $28,085	-10,802 Reduced 22.1%	38,085 $64,000
Q1 2023 May 15, 2023	BUY	$1.81 - $4.0 $25,359 - $56,044	14,011 Added 40.17%	48,887 $99,000
Q4 2022 Feb 14, 2023	BUY	$3.27 - $5.5 $25,479 - $42,856	7,792 Added 28.77%	34,876 $115,000
Q3 2022 Nov 14, 2022	BUY	$4.23 - $6.54 $6,019 - $9,306	1,423 Added 5.55%	27,084 $122,000

Others Institutions Holding INCR

# of Institutions

Shares Held

3.32M

Call Options Held

Put Options Held

View Full List

About Intercure Ltd.

Ticker INCR
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 45,133,900
Market Cap $78.1M
Description
InterCure Ltd., together with its subsidiaries, engages in the research, cultivation, production, marketing, and distribution of medical cannabis products in Israel and internationally. It offers dried cannabis inflorescences and cannabis extract mixed with oil. The company also invests in biomed sector. InterCure Ltd. was incorporated in 1994 a...

More about INCR

Track Ken Griffin's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.

Account